Akero Therapeutics Shares Plummet Premarket After NASH Study Update Markets – MarketWatch

Akero Therapeutics Shares Plummet Premarket After NASH Study Update Markets – MarketWatch

 

By Colin Kellaher Shares of Akero Therapeutics plunged in premarket trading Tuesday after the biotechnology company gave an interim update on a Phase 2b…

  

Read More 

Markets – MarketWatch 

​